To include your compound in the COVID-19 Resource Center, submit it here.

Advexin: Phase I/II

The National Cancer Institute began an open-label Phase I/II

Read the full 90 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE